Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target…

Overview of attention for article published in The Lancet, October 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 34 news outlets
blogs: 3 blogs
twitter: 41 X users
facebook: 1 Facebook page

wikipedia: 2 Wikipedia pages
video: 1 YouTube creator
guideline: 2 clinical guideline sources
podcasts: 2 podcasts

Readers on

mendeley: 104 Mendeley

So far, Altmetric has seen 2 citations on 2 Wikipedia pages.

Insulin icodec

Cited by user Shadowfax0 on 17 Jun 2026

Insulin icodec, sold under the brand name Awiqli, is an ultralong-acting basal insulin analogue used in the treatment of diabetes mellitus.

Insulina icodec

Cited by user OppidumNissenae on 28 May 2024

L insulina icodec (LAI287, NN1436) è una formulazione di insulina sintetica della Novo Nordisk, in corso di sviluppo, analogo dell'insulina basale.

This page shows the most recent Wikipedia articles that mention this research output. Click here to find out how to access more activity.